Clinical Trials Logo
  1. Home
  2. Acute Pancreatitis
  3. NCT04990336
  4. Details
NCT04990336 Clinical Trial

Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis

Acute Pancreatitis Clinical Trial

Official title:
Comparison of Clinical Efficacy of Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04990336
Other study ID # ZDWY.XHNK.003
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2023
Est. completion date July 31, 2029

Study information
Verified date July 2021
Source Fifth Affiliated Hospital, Sun Yat-Sen University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A large number of clinical studies have shown that oral administration, external application or enema of Chinese medicine can promote the recovery of gastrointestinal function and the absorption of pancreatic inflammation. The aims of the study is to explore the application of Dachaihu Decoction Compound (DDC)and Rhubarb Single Medicine (RSM) in the Treatment of Acute Pancreatitis.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 306
Est. completion date July 31, 2029
Est. primary completion date January 31, 2029
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Age from 18 to 65 years old - Meet the diagnostic criteria of western medicine for acute pancreatitis, within 48 hours of onset - Consent of the subjects, who sign the informed consent form Exclusion Criteria: - Women who are pregnant or breastfeeding - Acute abdomen such as organic intestinal obstruction, gastrointestinal perforation, purulent cholangitis, etc. - Patients with a history of severe heart, liver, kidney and other important organ diseases - Patients with mental illness and malignant tumors - People who have allergies, or are allergic to a certain drug ingredient

Study Design

Related Conditions & MeSH terms

Intervention

Combination Product:
• Dachaihu decoction compound
Dachaihu decoction compound includes Bupleurum, Rhubarb, Citrus aurantium, Scutellaria, Pinellia, White Peony, Jujube, Ginger.
Drug:
• Rhubarb single medicine
Rhubarb single medicine
Combination Product:
• Regular therapies
Regular therapies, such as fluid therapy, for acute pancreatitis

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Fifth Affiliated Hospital, Sun Yat-Sen University

Outcome
Type Measure Description Time frame Safety issue
Primary Significant and effective rate Significant and effective rate after 7 days of treatment 7 days
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05410795 - Establishment and Verification of Pancreatic Volume Formula Based on Imaging
Recruiting NCT04195347 - Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase Phase 1/Phase 2
Completed NCT04735055 - Artificial Intelligence Prediction for the Severity of Acute Pancreatitis
Completed NCT02928718 - The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations
Terminated NCT02885441 - Treatment of Acute Pancreatitis With Ketorolac Phase 4
Completed NCT02563080 - Pancreatic Exocrine Insufficiency in Acute Pancreatitis
Recruiting NCT01626911 - Continuous Regional Arterial Infusion of Low Molecular Weight Heparin in Patients With Severe Acute Pancreatitis N/A
Completed NCT01507766 - The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis Phase 4
Completed NCT04901949 - The Course of Acute Pancreatitis in Patients With Different BMI Groups
Recruiting NCT04814693 - Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis N/A
Completed NCT02743364 - Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis Phase 2
Recruiting NCT05281458 - Early Versus Standard Endoscopic Interventions for Peripancreatic Fluid Collections N/A
Not yet recruiting NCT03259880 - Searching the Best Prognostic Factor in Out Come Evaluation in Patients With Acute Pancreatitis Admitted at Assiut University Hospitals N/A
Completed NCT02543658 - Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension Phase 2
Recruiting NCT06023771 - Invasive Intervention of Local Complications of Acute Pancreatitis
Not yet recruiting NCT05501314 - Remote Home Monitoring Acute Pancreatitis N/A
Completed NCT02897206 - Imipenem Prophylaxis in Patients With Acute Pancreatitis Phase 4
Recruiting NCT03634787 - Heat Shock Proteins: a Pathogenic Driver and Potential Therapeutic Target in Acute Pancreatitis
Active, not recruiting NCT04989166 - Effect of Nano-curcumin Supplementation in Acute Pancreatitis N/A
Recruiting NCT05613673 - Prognostic Value of Different Nutritional Screening Tools in Acute Pancreatitis